Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Length of Symptoms Before Referral: Prognostic Variable for High-grade Soft Tissue Sarcoma?

Identifieur interne : 004D93 ( Main/Exploration ); précédent : 004D92; suivant : 004D94

Length of Symptoms Before Referral: Prognostic Variable for High-grade Soft Tissue Sarcoma?

Auteurs : Bruce T. Rougraff [États-Unis] ; Jackie Lawrence [États-Unis] ; Kenneth Davis [États-Unis]

Source :

RBID : PMC:3270193

Abstract

Background

It is commonly assumed patients with high-grade soft tissue sarcomas who are diagnosed and treated quickly after the first onset of symptoms fare better than those with longer symptoms before treatment. The literature contains no substantive data to support this assumption for soft tissue sarcomas, particularly for high-grade lesions.

Questions/purposes

We examined selected potential prognostic factors for high-grade soft tissue sarcoma and determined whether the time from first symptom to diagnosis has an impact on survival or disease-free survival and whether subcutaneous sarcomas are diagnosed more quickly than deep sarcomas.

Methods

We retrospectively reviewed 381 consecutive patients treated for high-grade soft tissue sarcoma between 1992 and 2007. Each patient’s time from first symptom (pain and/or palpable mass) was prospectively entered into a surgical oncology database. The patients were followed for disease recurrence and survival. We compared length of symptoms with disease-free survival, overall survival, metastases at diagnosis, tumor size, and patient age. Minimum followup was 1 month (mean, 57 months; range, 1–201 months).

Results

The overall 5-year survival was 64.7% and disease-free survival was 54.5%. Tumor size and metastatic disease correlated with overall survival and disease-free survival but not length of symptoms. Length of symptoms did not correlate with overall survival or disease-free survival.

Conclusions

Our data do not support the assumption that longer length of symptoms before diagnosis predicts worse overall survival, disease-free survival, or metastatic disease at diagnosis.

Level of Evidence

Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.


Url:
DOI: 10.1007/s11999-011-2192-4
PubMed: 22183474
PubMed Central: 3270193


Affiliations:

Links toward previous steps (curation, corpus...)

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Length of Symptoms Before Referral: Prognostic Variable for High-grade Soft Tissue Sarcoma?</title>
<author>
<name sortKey="Rougraff, Bruce T" sort="Rougraff, Bruce T" uniqKey="Rougraff B" first="Bruce T." last="Rougraff">Bruce T. Rougraff</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lawrence, Jackie" sort="Lawrence, Jackie" uniqKey="Lawrence J" first="Jackie" last="Lawrence">Jackie Lawrence</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Davis, Kenneth" sort="Davis, Kenneth" uniqKey="Davis K" first="Kenneth" last="Davis">Kenneth Davis</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22183474</idno>
<idno type="pmc">3270193</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270193</idno>
<idno type="RBID">PMC:3270193</idno>
<idno type="doi">10.1007/s11999-011-2192-4</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000B16</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B16</idno>
<idno type="wicri:Area/Pmc/Curation">000B15</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B15</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002F00</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002F00</idno>
<idno type="wicri:Area/Ncbi/Merge">004914</idno>
<idno type="wicri:Area/Ncbi/Curation">004914</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004914</idno>
<idno type="wicri:doubleKey">0009-921X:2011:Rougraff B:length:of:symptoms</idno>
<idno type="wicri:Area/Main/Merge">004E29</idno>
<idno type="wicri:Area/Main/Curation">004D93</idno>
<idno type="wicri:Area/Main/Exploration">004D93</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Length of Symptoms Before Referral: Prognostic Variable for High-grade Soft Tissue Sarcoma?</title>
<author>
<name sortKey="Rougraff, Bruce T" sort="Rougraff, Bruce T" uniqKey="Rougraff B" first="Bruce T." last="Rougraff">Bruce T. Rougraff</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Lawrence, Jackie" sort="Lawrence, Jackie" uniqKey="Lawrence J" first="Jackie" last="Lawrence">Jackie Lawrence</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Davis, Kenneth" sort="Davis, Kenneth" uniqKey="Davis K" first="Kenneth" last="Davis">Kenneth Davis</name>
<affiliation wicri:level="2">
<nlm:aff id="Aff1"> OrthoIndy, 8450 Northwest Blvd, Indianapolis, IN 46278 USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Indiana</region>
</placeName>
<wicri:cityArea> OrthoIndy, 8450 Northwest Blvd, Indianapolis</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical Orthopaedics and Related Research</title>
<idno type="ISSN">0009-921X</idno>
<idno type="eISSN">1528-1132</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background</title>
<p>It is commonly assumed patients with high-grade soft tissue sarcomas who are diagnosed and treated quickly after the first onset of symptoms fare better than those with longer symptoms before treatment. The literature contains no substantive data to support this assumption for soft tissue sarcomas, particularly for high-grade lesions.</p>
</sec>
<sec>
<title>Questions/purposes</title>
<p>We examined selected potential prognostic factors for high-grade soft tissue sarcoma and determined whether the time from first symptom to diagnosis has an impact on survival or disease-free survival and whether subcutaneous sarcomas are diagnosed more quickly than deep sarcomas.</p>
</sec>
<sec>
<title>Methods</title>
<p>We retrospectively reviewed 381 consecutive patients treated for high-grade soft tissue sarcoma between 1992 and 2007. Each patient’s time from first symptom (pain and/or palpable mass) was prospectively entered into a surgical oncology database. The patients were followed for disease recurrence and survival. We compared length of symptoms with disease-free survival, overall survival, metastases at diagnosis, tumor size, and patient age. Minimum followup was 1 month (mean, 57 months; range, 1–201 months).</p>
</sec>
<sec>
<title>Results</title>
<p>The overall 5-year survival was 64.7% and disease-free survival was 54.5%. Tumor size and metastatic disease correlated with overall survival and disease-free survival but not length of symptoms. Length of symptoms did not correlate with overall survival or disease-free survival.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Our data do not support the assumption that longer length of symptoms before diagnosis predicts worse overall survival, disease-free survival, or metastatic disease at diagnosis.</p>
</sec>
<sec>
<title>Level of Evidence</title>
<p>Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.</p>
</sec>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Indiana</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Indiana">
<name sortKey="Rougraff, Bruce T" sort="Rougraff, Bruce T" uniqKey="Rougraff B" first="Bruce T." last="Rougraff">Bruce T. Rougraff</name>
</region>
<name sortKey="Davis, Kenneth" sort="Davis, Kenneth" uniqKey="Davis K" first="Kenneth" last="Davis">Kenneth Davis</name>
<name sortKey="Lawrence, Jackie" sort="Lawrence, Jackie" uniqKey="Lawrence J" first="Jackie" last="Lawrence">Jackie Lawrence</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D93 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004D93 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3270193
   |texte=   Length of Symptoms Before Referral: Prognostic Variable for High-grade Soft Tissue Sarcoma?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22183474" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024